Breast-Feeding and Responses to Infant Vaccines: Constitutional and Environmental Factors

 

 Buy Article Permissions and Reprints

Abstract

Neonates and nursing infants are special with regard to immune development and vulnerability to infectious diseases. Although breast-feeding is essential to modulate and prime immune defenses, vaccines (an interventional prophylaxis) are crucial to prevent and control infectious diseases. During nursing, the type of feeding influences infants' natural defenses (including gut colonization) and their response to vaccines, both through cell-mediated immunity and specific antibody production. Given the variety and combination of vaccine components (antigens and excipients, preservative thimerosal, and aluminum adjuvants) and route of administration, there is a need to examine the role of infant feeding practices in intended and nonintended outcomes of vaccination. Maternal factors related to milk constituents (nutrients and pollutants) and feeding practices can affect response to vaccines. Collectively, studies that compared type of feeding (or used breast-feeding-adjusted statistical models) showed significant influence on some vaccines taken during infancy. Nurslings deprived of the full benefit of breast-feeding could have altered immune responses affecting vaccine outcome. In the absence of studies elucidating neurodevelopment (including excitoxicity) and immunotoxicity issues, vaccination practices should promote and support breast-feeding.

• References

• 1 Verhasselt V. Neonatal tolerance under breastfeeding influence. Curr Opin Immunol 2010; 22: 623-630
  CrossrefPubMedGoogle Scholar
• 2 Ladomenou F, Moschandreas J, Kafatos A, Tselentis Y, Galanakis E. Protective effect of exclusive breastfeeding against infections during infancy: a prospective study. Arch Dis Child 2010; 95: 1004-1008
  CrossrefPubMedGoogle Scholar
• 3 Shann F, Nohynek H, Scott JA, Hesseling A, Flanagan KL ; Working Group on Nonspecific Effects of Vaccines. Randomized trials to study the nonspecific effects of vaccines in children in low-income countries. Pediatr Infect Dis J 2010; 29: 457-461
  PubMedGoogle Scholar
• 4 Hanson LA, Silfverdal SA. Vaccination immunology. Scand J Infect Dis 2008; 40: 696-701
  CrossrefPubMedGoogle Scholar
• 5 Savy M, Edmond K, Fine PE , et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr 2009; 139: 2154S-2218S
  CrossrefPubMedGoogle Scholar
• 6 Prentice AM, van der Merwe L. Impact of fatty acid status on immune function of children in low-income countries. Matern Child Nutr 2011; 7 (Suppl. 02) 89-98
  CrossrefPubMedGoogle Scholar
• 7 Cummins AG, Thompson FM. Postnatal changes in mucosal immune response: a physiological perspective of breast feeding and weaning. Immunol Cell Biol 1997; 75: 419-429
  CrossrefPubMedGoogle Scholar
• 8 Pabst HF. Immunomodulation by breast-feeding. Pediatr Infect Dis J 1997; 16: 991-995
  PubMedGoogle Scholar
• 9 Webster LT, Pritchett IW. Microbic virulence and host susceptibility in paratyphoid-enteritidis infection of white mice: V. The effect of diet on host resistance. J Exp Med 1924; 40: 403
  PubMedGoogle Scholar
• 10 Siegrist CA. Neonatal and early life vaccinology. Vaccine 2001; 19: 3331-3346
  CrossrefPubMedGoogle Scholar
• 11 Pickering LK, Granoff DM, Erickson JR , et al. Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics 1998; 101: 242-249
  CrossrefPubMedGoogle Scholar
• 12 Sabirov A, Casey JR, Murphy TF, Pichichero ME. Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6. Pediatr Res 2009; 66: 565-570
  CrossrefPubMedGoogle Scholar
• 13 Van Loveren H, Vos J, Putman E, Piersma A. Immunotoxicological consequences of perinatal chemical exposures: a plea for inclusion of immune parameters in reproduction studies. Toxicology 2003; 185: 185-191
  CrossrefPubMedGoogle Scholar
• 14 Kassim OO, Raphael DH, Ako-Nai AK, Taiwo O, Torimiro SE, Afolabi OO. Class-specific antibodies to Bordetella pertussis, Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis in human breast-milk and maternal-infant sera. Ann Trop Paediatr 1989; 9: 226-232
  PubMedGoogle Scholar
• 15 Amoudruz P, Holmlund U, Schollin J, Sverremark-Ekström E, Montgomery SM. Maternal country of birth and previous pregnancies are associated with breast milk characteristics. Pediatr Allergy Immunol 2009; 20: 19-29
  CrossrefPubMedGoogle Scholar
• 16 Holmlund U, Amoudruz P, Johansson MA , et al. Maternal country of origin, breast milk characteristics and potential influences on immunity in offspring. Clin Exp Immunol 2010; 162: 500-509
  CrossrefPubMedGoogle Scholar
• 17 Roberton DM, Carlsson B, Coffman K , et al. Avidity of IgA antibody to Escherichia coli polysaccharide and diphtheria toxin in breast milk from Swedish and Pakistani mothers. Scand J Immunol 1988; 28: 783-789
  CrossrefPubMedGoogle Scholar
• 18 Svennerholm AM, Hanson LA, Holmgren J , et al. Antibody responses to live and killed poliovirus vaccines in the milk of Pakistani and Swedish women. J Infect Dis 1981; 143: 707-711
  CrossrefPubMedGoogle Scholar
• 19 Brüssow H, Benitez O, Uribe F, Sidoti J, Rosa K, Cravioto A. Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life. J Clin Microbiol 1993; 31: 593-597
  PubMedGoogle Scholar
• 20 Chan J, Nirwati H, Triasih R , et al. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?. Vaccine 2011; 29: 1242-1247
  CrossrefPubMedGoogle Scholar
• 21 Odoemele CF, Ukwandu NC, Adu FD , et al. Seroconversion of children following natural measles infection and vaccination. J Pak Med Assoc 2008; 58: 501-505
  PubMedGoogle Scholar
• 22 McDade TW, Beck MA, Kuzawa C, Adair LS. Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. Am J Clin Nutr 2001; 74: 543-548
  PubMedGoogle Scholar
• 23 Newton S, Cousens S, Owusu-Agyei S , et al. Vitamin a supplementation does not affect infants' immune responses to polio and tetanus vaccines. J Nutr 2005; 135: 2669-2673
  PubMedGoogle Scholar
• 24 Bhaskaram P, Balakrishna N. Effect of administration of 200,000 IU of vitamin A to women within 24 hrs after delivery on response to PPV administered to the newborn. Indian Pediatr 1998; 35: 217-222
  PubMedGoogle Scholar
• 25 Bahl R, Kumar R, Bhandari N, Kant S, Srivastava R, Bhan MK. Vitamin A administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity. J Nutr 1999; 129: 1569-1573
  PubMedGoogle Scholar
• 26 Bahl R, Bhandari N, Kant S, Mølbak K, Østergaard E, Bhan MK. Effect of vitamin A administered at Expanded Program on Immunization contacts on antibody response to oral polio vaccine. Eur J Clin Nutr 2002; 56: 321-325
  CrossrefPubMedGoogle Scholar
• 27 Furuhjelm C, Jenmalm MC, Fälth-Magnusson K, Duchén K. Th1 and Th2 chemokines, vaccine-induced immunity, and allergic disease in infants after maternal ω-3 fatty acid supplementation during pregnancy and lactation. Pediatr Res 2011; 69: 259-264
  CrossrefPubMedGoogle Scholar
• 28 Ahmed T, Svennerholm AM, Al Tarique A, Sultana GN, Qadri F. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine 2009; 27: 1433-1439
  CrossrefPubMedGoogle Scholar
• 29 Ostrom KM, Cordle CT, Schaller JP , et al. Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 1: vaccine responses, and morbidity. J Pediatr Gastroenterol Nutr 2002; 34: 137-144
  CrossrefPubMedGoogle Scholar
• 30 Schaller JP, Kuchan MJ, Thomas DL , et al. Effect of dietary ribonucleotides on infant immune status. Part 1: Humoral responses. Pediatr Res 2004; 56: 883-890
  CrossrefPubMedGoogle Scholar
• 31 Buck RH, Thomas DL, Winship TR , et al. Effect of dietary ribonucleotides on infant immune status. Part 2: Immune cell development. Pediatr Res 2004; 56: 891-900
  CrossrefPubMedGoogle Scholar
• 32 Hahn-Zoric M, Fulconis F, Minoli I , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatr Scand 1990; 79: 1137-1142
  PubMedGoogle Scholar
• 33 Zoppi G, Mantovanelli F, Pittschieler K, Delem A, Teuwen DE. Response to RIT 4237 oral rotavirus vaccine in human milk, adapted- and soy-formula fed infants. Acta Paediatr Scand 1989; 78: 759-762
  CrossrefPubMedGoogle Scholar
• 34 Hawkes JS, Gibson RA, Roberton D, Makrides M. Effect of dietary nucleotide supplementation on growth and immune function in term infants: a randomized controlled trial. Eur J Clin Nutr 2006; 60: 254-264
  CrossrefPubMedGoogle Scholar
• 35 Yau KI, Huang CB, Chen W , et al. Effect of nucleotides on diarrhea and immune responses in healthy term infants in Taiwan. J Pediatr Gastroenterol Nutr 2003; 36: 37-43
  CrossrefPubMedGoogle Scholar
• 36 West CE, Gothefors L, Granström M, Käyhty H, Hammarström ML, Hernell O. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol 2008; 19: 53-60
  PubMedGoogle Scholar
• 37 Belcaro G, Cesarone MR, Cornelli U , et al. Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study. Panminerva Med 2010; 52: 269-275
  PubMedGoogle Scholar
• 38 Pérez N, Iannicelli JC, Girard-Bosch C , et al. Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status. Eur J Nutr 2010; 49: 173-179
  CrossrefPubMedGoogle Scholar
• 39 Gibson RA, Barclay D, Marshall H, Moulin J, Maire JC, Makrides M. Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. Br J Nutr 2009; 101: 1706-1713
  CrossrefPubMedGoogle Scholar
• 40 Taylor AL, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clin Exp Allergy 2006; 36: 1227-1235
  CrossrefPubMedGoogle Scholar
• 41 Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy—a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol 2006; 17: 416-421
  CrossrefPubMedGoogle Scholar
• 42 Firmansyah A, Dwipoerwantoro PG, Kadim M , et al. Improved growth of toddlers fed a milk containing synbiotics. Asia Pac J Clin Nutr 2011; 20: 69-76
  PubMedGoogle Scholar
• 43 Stam J, van Stuijvenberg M, Garssen J, Knipping K, Sauer PJ. A mixture of three prebiotics does not affect vaccine specific antibody responses in healthy term infants in the first year of life. Vaccine 2011; 29: 7766-7772
  CrossrefPubMedGoogle Scholar
• 44 Weisglas-Kuperus N, Patandin S, Berbers GA , et al. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect 2000; 108: 1203-1207
  CrossrefPubMedGoogle Scholar
• 45 Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jørgensen E. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med 2006; 3: e311
  CrossrefPubMedGoogle Scholar
• 46 Heilmann C, Budtz-Jørgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P. Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ Health Perspect 2010; 118: 1434-1438
  CrossrefPubMedGoogle Scholar
• 47 Jusko TA, De Roos AJ, Schwartz SM , et al. A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age. Environ Res 2010; 110: 388-395
  CrossrefPubMedGoogle Scholar
• 48 Grandjean P, Andersen EW, Budtz-Jørgensen E , et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 2012; 307: 391-397
  CrossrefPubMedGoogle Scholar
• 49 El-Hawary MF, Soliman AA, Nosseir SA, Kholief TS. Biochemical studies on the effect of breast and artificial feeding in newborn Egyptian infants. I. Serum proteins and immunoglobulins in 1–4-day-old newborns. Z Ernahrungswiss 1981; 20: 283-290
  CrossrefPubMedGoogle Scholar
• 50 Kanariou M, Petridou E, Liatsis M, Revinthi K, Mandalenaki-Lambrou K, Trichopoulos D. Age patterns of immunoglobulins G, A & M in healthy children and the influence of breast feeding and vaccination status. Pediatr Allergy Immunol 1995; 6: 24-29
  CrossrefPubMedGoogle Scholar
• 51 Krogh V, Duffy LC, Wong D, Rosenband M, Riddlesberger KR, Ogra PL. Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants. J Lab Clin Med 1989; 113: 699
  PubMedGoogle Scholar
• 52 Oyedele OO, Odemuyiwa SO, Ammerlaan W, Muller CP, Adu FD. Passive immunity to measles in the breastmilk and cord blood of some Nigerian subjects. J Trop Pediatr 2005; 51: 45-48
  CrossrefPubMedGoogle Scholar
• 53 Hahn-Zoric M, Carlsson B, Jalil F, Mellander L, Germanier R, Hanson LA. The influence on the secretory IgA antibody levels in lactating women of oral typhoid and parenteral cholera vaccines given alone or in combination. Scand J Infect Dis 1989; 21: 421-426
  CrossrefPubMedGoogle Scholar
• 54 Clemens JD, Sack DA, Harris JR , et al. Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am J Epidemiol 1990; 131: 400-411
  PubMedGoogle Scholar
• 55 Qureshi K, Mølbak K, Sandström A , et al. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Pediatr Infect Dis J 2006; 25: 1163-1166
  PubMedGoogle Scholar
• 56 Bruhn K, Tillett J. Administration of vaccinations in pregnancy and postpartum. MCN Am J Matern Child Nurs 2009; 34: 98-105
  CrossrefPubMedGoogle Scholar
• 57 Centers for Disease Control and Prevention (CDC). Transmission of yellow fever vaccine virus through breast-feeding—Brazil, 2009. MMWR Morb Mortal Wkly Rep 2010; 59: 130-132
  PubMedGoogle Scholar
• 58 Chen LH, Zeind C, Mackell S, LaPointe T, Mutsch M, Wilson ME. Yellow fever virus transmission via breastfeeding: follow-up to the paper on breastfeeding travelers. J Travel Med 2010; 17: 286-287
  PubMedGoogle Scholar
• 59 Kuhn S, Twele-Montecinos L, MacDonald J, Webster P, Law B. Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk. CMAJ 2011; 183: E243-E245
  CrossrefPubMedGoogle Scholar
• 60 Traiber C, Coelho-Amaral P, Ritter VR, Winge A. Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk. J Pediatr (Rio J) 2011; 87: 269-272
  PubMedGoogle Scholar
• 61 Rowe J, Poolman JT, Macaubas C, Sly PD, Loh R, Holt PG. Enhancement of vaccine-specific cellular immunity in infants by passively acquired maternal antibody. Vaccine 2004; 22: 3986-3992
  CrossrefPubMedGoogle Scholar
• 62 Deubzer HE, Obaro SK, Newman VO, Adegbola RA, Greenwood BM, Henderson DC. Colostrum obtained from women vaccinated with pneumococcal vaccine during pregnancy inhibits epithelial adhesion of Streptococcus pneumoniae . J Infect Dis 2004; 190: 1758-1761
  CrossrefPubMedGoogle Scholar
• 63 Obaro SK, Deubzer HE, Newman VO, Adegbola RA, Greenwood BM, Henderson DC. Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. Pediatr Infect Dis J 2004; 23: 1023-1029
  PubMedGoogle Scholar
• 64 Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 2003; 21: 3465-3467
  CrossrefPubMedGoogle Scholar
• 65 Lopes CR, Berezin EN, Ching TH, Canuto JdeS, Costa VO, Klering EM. Ineffectiveness for infants of immunization of mothers with pneumococcal capsular polysaccharide vaccine during pregnancy. Braz J Infect Dis 2009; 13: 104-106
  PubMedGoogle Scholar
• 66 Shahid NS, Steinhoff MC, Hoque SS, Begum T, Thompson C, Siber GR. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1995; 346: 1252-1257
  CrossrefPubMedGoogle Scholar
• 67 Leuridan E, Hens N, Peeters N, de Witte L, Van der Meeren O, Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011; 30: 608-610
  PubMedGoogle Scholar
• 68 Halperin BA, Morris A, Mackinnon-Cameron D , et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011; 53: 885-892
  CrossrefPubMedGoogle Scholar
• 69 de Martino M, Resti M, Appendino C, Vierucci A. Different degree of antibody response to hepatitis B virus vaccine in breast- and formula-fed infants born to HBsAg-positive mothers. J Pediatr Gastroenterol Nutr 1987; 6: 208-211
  CrossrefPubMedGoogle Scholar
• 70 Azzari C, Resti M, Rossi ME, Lami CA, Vierucci A. Modulation by human milk of IgG subclass response to hepatitis B vaccine in infants. J Pediatr Gastroenterol Nutr 1990; 10: 310-315
  CrossrefPubMedGoogle Scholar
• 71 Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 2003; 57: 100-102
  PubMedGoogle Scholar
• 72 Poland GA, Ovsyannikova IG, Jacobson RM. Adversomics: the emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J 2009; 28: 431-432
  PubMedGoogle Scholar
• 73 Levine MM. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol 2010; 8: 129
  CrossrefPubMedGoogle Scholar
• 74 Pabst HF, Spady DW, Pilarski LM, Carson MM, Beeler JA, Krezolek MP. Differential modulation of the immune response by breast- or formula-feeding of infants. Acta Paediatr 1997; 86: 1291-1297
  CrossrefPubMedGoogle Scholar
• 75 Halsey N, Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ 1985; 63: 1151-1169
  PubMedGoogle Scholar
• 76 Dömök I, Balayan MS, Fayinka OA, Skrtić N, Soneji AD, Harland PS. Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. Bull World Health Organ 1974; 51: 333-347
  PubMedGoogle Scholar
• 77 Chopra K, Kundu S, Chowdhury DS. Antibody response of infants in tropics to five doses of oral polio vaccine. J Trop Pediatr 1989; 35: 19-23
  CrossrefPubMedGoogle Scholar
• 78 Pichichero ME. Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis. J Infect Dis 1990; 162: 753-755
  CrossrefPubMedGoogle Scholar
• 79 Glass RI, Ing DJ, Stoll BJ, Ing RT. Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children. Adv Exp Med Biol 1991; 310: 249-254
  PubMedGoogle Scholar
• 80 Rennels MB. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 1996; 174 (Suppl. 01) S107-S111
  CrossrefPubMedGoogle Scholar
• 81 Pichichero ME, Losonsky GA, Rennels MB , et al; The Maryland Clinical Studies Group. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. Pediatr Infect Dis J 1990; 9: 339-344
  PubMedGoogle Scholar
• 82 Rennels MB, Ward RL, Mack ME, Zito ET ; The US Rotavirus Vaccine Efficacy Group. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. J Infect Dis 1996; 173: 306-313
  CrossrefPubMedGoogle Scholar
• 83 Vesikari T, Ruuska T, Bogaerts H, Delem A, André F. Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. Pediatr Infect Dis 1985; 4: 622-625
  PubMedGoogle Scholar
• 84 Vesikari T, Ruuska T, Delem A, André FE. Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months. Acta Paediatr Scand 1986; 75: 573-578
  CrossrefPubMedGoogle Scholar
• 85 Vesikari T, Prymula R, Schuster V , et al. Efficacy and Immunogenicity of Live-Attenuated Human Rotavirus Vaccine in Breast-Fed and Formula-Fed European Infants. Pediatr Infect Dis J 2012; 2012: 132876
  PubMedGoogle Scholar
• 86 Scheifele D, Bjornson GJ, Guasparini R, Friesen B, Meekison W. Breastfeeding and antibody responses to routine vaccination in infants. Lancet 1992; 340: 1406
  PubMedGoogle Scholar
• 87 Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, Andre FE. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vaccine 1986; 4: 233-236
  CrossrefPubMedGoogle Scholar
• 88 Ho MS, Floyd RL, Glass RI , et al. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Pediatr Infect Dis J 1989; 8: 692-696
  PubMedGoogle Scholar
• 89 Moon SS, Wang Y, Shane AL , et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J 2010; 29: 919-923
  PubMedGoogle Scholar
• 90 John TJ, Devarajan LV, Luther L, Vijayarathnam P. Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination. Pediatrics 1976; 57: 47-53
  PubMedGoogle Scholar
• 91 Deforest A, Parker PB, DiLiberti JH, Yates Jr HT, Sibinga MS, Smith DS. The effect of breast-feeding on the antibody response of infants to trivalent oral poliovirus vaccine. J Pediatr 1973; 83: 93-95
  PubMedGoogle Scholar
• 92 Pabst HF, Godel J, Grace M, Cho H, Spady DW. Effect of breast-feeding on immune response to BCG vaccination. Lancet 1989; 1: 295-297
  PubMedGoogle Scholar
• 93 Goh TE, Low M, Chen CH, Tan TH. A comparative study of Japanese and British BCG vaccine strains in newborn infants. Asia Pac J Public Health 1989; 3: 32-40
  CrossrefPubMedGoogle Scholar
• 94 Silfverdal SA, Ehlin A, Montgomery SM. Breast-feeding and a subsequent diagnosis of measles. Acta Paediatr 2009; 98: 715-719
  CrossrefPubMedGoogle Scholar
• 95 Shi Z, Yang Y, Wang H , et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med 2011; 165: 837-846
  CrossrefPubMedGoogle Scholar
• 96 Pabst HF, Spady DW. Effect of breast-feeding on antibody response to conjugate vaccine. Lancet 1990; 336: 269-270
  CrossrefPubMedGoogle Scholar
• 97 Silfverdal SA, Bodin L, Olcén P. Protective effect of breastfeeding: an ecologic study of Haemophilus influenzae meningitis and breastfeeding in a Swedish population. Int J Epidemiol 1999; 28: 152-156
  CrossrefPubMedGoogle Scholar
• 98 Silfverdal SA, Bodin L, Ulanova M, Hahn-Zoric M, Hanson LA, Olcen P. Long term enhancement of the IgG2 antibody response to Haemophilus influenzae type b by breast-feeding. Pediatr Infect Dis J 2002; 21: 816-821
  PubMedGoogle Scholar
• 99 Silfverdal SA, Bodin L, Ulanova M, Hahn-Zoric M, Hanson LA, Olcén P. Expression of idiotypic antibodies-1 and -2 and breastfeeding in relation to antibody levels against Haemophilus influenzae type B in children. Scand J Immunol 2006; 63: 371-375
  CrossrefPubMedGoogle Scholar
• 100 Silfverdal SA, Ekholm L, Bodin L. Breastfeeding enhances the antibody response to Hib and Pneumococcal serotype 6B and 14 after vaccination with conjugate vaccines. Vaccine 2007; 25: 1497-1502
  CrossrefPubMedGoogle Scholar
• 101 Hawkes JS, Makrides M, Roberton DM, Gibson RA. Responses to immunisation with Hib conjugate vaccine in Australian breastfed and formula-fed infants. J Paediatr Child Health 2007; 43: 597-600
  CrossrefPubMedGoogle Scholar
• 102 Stephens S, Kennedy CR, Lakhani PK, Brenner MK. In-vivo immune responses of breast- and bottle-fed infants to tetanus toxoid antigen and to normal gut flora. Acta Paediatr Scand 1984; 73: 426-432
  CrossrefPubMedGoogle Scholar
• 103 Watemberg N, Dagan R, Arbelli Y , et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991; 10: 758-763
  PubMedGoogle Scholar
• 104 Moore SE, Collinson AC, Fulford AJ , et al. Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop Med Int Health 2006; 11: 1529-1541
  CrossrefPubMedGoogle Scholar
• 105 Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources of mercury. JAMA 1999; 282: 1763-1766
  CrossrefPubMedGoogle Scholar
• 106 Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics 2001; 107: 1147-1154
  CrossrefPubMedGoogle Scholar
• 107 Garay PA, McAllister AK. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front Synaptic Neurosci 2010; 2: 136
  PubMedGoogle Scholar
• 108 Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011; 23: 187-192
  CrossrefPubMedGoogle Scholar
• 109 Gandra YR, Scrimsha W NS. Infection and nutritional status. II. Effect of mild virus infection induced by 17-D yellow fever vaccine on nitrogen metabolism in children. Am J Clin Nutr 1961; 9: 159-163
  PubMedGoogle Scholar
• 110 Hentges EJ, Marple DN, Roland Sr DA, Pritchett JF. Muscle protein synthesis and growth of two strains of chicks vaccinated for Newcastle disease and infectious bronchitis. Poult Sci 1984; 63: 1738-1741
  CrossrefPubMedGoogle Scholar
• 111 Long SS, Deforest A, Smith DG, Lazaro C, Wassilak GF. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics 1990; 85: 294-302
  PubMedGoogle Scholar
• 112 Dòrea JG. Breastfeeding is an essential complement to vaccination. Acta Paediatr 2009; 98: 1244-1250
  CrossrefPubMedGoogle Scholar
• 113 Sahebihag MH, Hosseinzadeh M, Mohammadpourasl A, Kosha A. The effect of breastfeeding, oral sucrose and combination of oral sucrose and breastfeeding in infant's pain relief during the vaccination. Iran J Nurs Midwifery Res 2011; 16: 9-15
  PubMedGoogle Scholar
• 114 Pisacane A, Continisio P, Palma O, Cataldo S, De Michele F, Vairo U. Breastfeeding and risk for fever after immunization. Pediatrics 2010; 125: e1448-e1452
  CrossrefPubMedGoogle Scholar
• 115 Monteiro SA, Takano OA, Waldman EA. Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting. Vaccine 2010; 28: 3127-3133
  CrossrefPubMedGoogle Scholar
• 116 Eales SJ. Hepatitis B vaccine at birth—just another barrier to breastfeeding?. Aust Midwifery 2003; 16: 4-5
  PubMedGoogle Scholar
• 117 López-Alarcón M, Garza C, Habicht JP, Martínez L, Pegueros V, Villalpando S. Breastfeeding attenuates reductions in energy intake induced by a mild immunologic stimulus represented by DPTH immunization: possible roles of interleukin-1beta, tumor necrosis factor-alpha and leptin. J Nutr 2002; 132: 1293-1298
  PubMedGoogle Scholar
• 118 López-Alarcón M, Garza C, del Prado M, García-Zúñiga PA, Barbosa L. Breastfeeding's protection against illness-induced anorexia is mediated partially by docosahexaenoic acid. Eur J Clin Nutr 2008; 62: 32-38
  CrossrefPubMedGoogle Scholar
• 119 Clemens JD, Ferreccio C, Levine MM , et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA 1992; 267: 673-678
  CrossrefPubMedGoogle Scholar
• 120 Gold R, Scheifele D, Barreto L , et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J 1994; 13: 348-355
  PubMedGoogle Scholar
• 121 Woodin KA, Rodewald LE, Humiston SG, Carges MS, Schaffer SJ, Szilagyi PG. Physician and parent opinions. Are children becoming pincushions from immunizations?. Arch Pediatr Adolesc Med 1995; 149: 845-849
  CrossrefPubMedGoogle Scholar
• 122 de La Calle Valverde A, González De Aledo Linos A. [Comparation of reactogenicity of vaccine combinations with an injection volume of 0,5 and 1 ml in infants]. Aten Primaria 2001; 28: 249-255
  CrossrefPubMedGoogle Scholar
• 123 Chandran A, Fitzwater S, Zhen A, Santosham M. Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics 2010; 4: 213-229
  PubMedGoogle Scholar
• 124 Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?. CMAJ 1993; 149: 1105-1112
  PubMedGoogle Scholar
• 125 Ferreccio C, Clemens J, Avendano A , et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991; 10: 764-771
  PubMedGoogle Scholar
• 126 Avendano A, Ferreccio C, Lagos R , et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1993; 12: 638-643
  PubMedGoogle Scholar
• 127 Sartono E, Lisse IM, Terveer EM , et al. Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment. PLoS ONE 2010; 5: e10328
  CrossrefPubMedGoogle Scholar
• 128 Agergaard J, Nante E, Poulstrup G , et al. Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau. Vaccine 2011; 29: 487-500
  CrossrefPubMedGoogle Scholar
• 129 Dórea JG. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines. Neurochem Res 2011; 36: 927-938
  CrossrefPubMedGoogle Scholar
• 130 Dórea JG, Bezerra VL, Fajon V, Horvat M. Speciation of methyl- and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines. Clin Chim Acta 2011; 412: 1563-1566
  CrossrefPubMedGoogle Scholar
• 131 Marques RC, Dórea JG, Bernardi JV, Bastos WR, Malm O. Prenatal and postnatal mercury exposure, breastfeeding and neurodevelopment during the first 5 years. Cogn Behav Neurol 2009; 22: 134-141
  CrossrefPubMedGoogle Scholar
• 132 Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants. Acta Paediatr 2007; 96: 864-868
  CrossrefPubMedGoogle Scholar
• 133 Marques RC, Dórea JG, Bernardi JV. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months. Acta Paediatr 2010; 99: 934-939
  PubMedGoogle Scholar
• 134 Lee BE, Ha EH. Response to commentary “Co-exposure and confounders during neurodevelopment: we need them in the bigger picture of secondhand smoke exposure during pregnancy.”. Environ Res 2012; 112: 235
  CrossrefPubMedGoogle Scholar
• 135 Jedrychowski W. Reply to the correspondence letter by M.D. Majewska: Krakow's children and cognitive function: can the study by Jedrychowski et al. show us the bigger picture?. Eur J Pediatr 2012; 171: 407
  CrossrefPubMedGoogle Scholar
• 136 Dórea JG, Marques RC, Isejima C. Neurodevelopment of Amazonian infants: antenatal and postnatal exposure to methyl- and ethyl-mercury. J Biom Biotechnol 2012; 2012: 132846
  PubMedGoogle Scholar
• 137 Goveia MG, DiNubile MJ, Dallas MJ, Heaton PM, Kuter BJ ; REST Study Team. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J 2008; 27: 656-658
  PubMedGoogle Scholar
• 138 Zaman S, Carlsson B, Jalil F, Jeansson S, Mellander L, Hanson LA. Specific antibodies to poliovirus type I in breastmilk of unvaccinated mothers before and seven years after start of community-wide vaccination of their infants with live, oral poliovirus vaccine. Acta Paediatr Scand 1991; 80: 1174-1182
  CrossrefPubMedGoogle Scholar
• 139 Ferreira RB, Antunes LC, Finlay BB. Should the human microbiome be considered when developing vaccines?. PLoS Pathog 2010; 6: e1001190
  CrossrefPubMedGoogle Scholar
• 140 Długońska H, Grzybowski M. Personalized vaccination? II. The role of natural microbiota in a vaccine-induced immunity. Wiad Parazytol 2011; 57: 71-76
  PubMedGoogle Scholar
• 141 de Palma O, Cruz L, Ramos H , et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340: c2825
  CrossrefPubMedGoogle Scholar
• 142 Triki H, Abdallah MV, Ben Aissa R , et al. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine 1997; 15: 1123-1129
  CrossrefPubMedGoogle Scholar
• 143 Campillo-Sainz C, Ornelas Hernandez A, De Mucha Macias J, Nava SE. Immunization of newborn children with living oral trivalent poliovirus vaccine. J Bacteriol 1962; 84: 446-450
  PubMedGoogle Scholar
• 144 Aaby P, Martins CL, Garly ML , et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010; 341: c6495
  CrossrefPubMedGoogle Scholar
• 145 Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992; 120 (2 Pt 1) 184-189
  PubMedGoogle Scholar
• 146 O'Brien KL, Moisi J, Moulton LH , et al. Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial. J Infect Dis 2007; 196: 104-114
  CrossrefPubMedGoogle Scholar